FDA NDC Directory · JSON-LD · Markdown

XENPOZYME

NDC 58468-0051 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameolipudase alfa-rpcp
Labeler / ManufacturerGenzyme Corporation
Marketing categoryBiologic License Application · App BLA761261
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsOLIPUDASE ALFA (4 mg/1.1mL)
Marketing started20220829
Package count1

External sources

Source: openFDA. Public-domain (CC0).